Medford, MA, United States of America

Paul J Higgins

This inventor holds 1 USPTO granted patent. Top assignee: Cytomed, Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul J Higgins. Retrieved from https://idiyas.com/inventor/paul-j-higgins-kjdpaxmc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Paul J. Higgins

Introduction

Paul J. Higgins is an accomplished inventor based in Medford, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of complement activation. His work has implications for reducing inflammation, which is crucial in various medical conditions.

Latest Patents

Higgins holds a patent for "Methods of inhibiting complement activation." This invention relates to novel chimeric proteins that comprise a first polypeptide and a second polypeptide, both of which inhibit complement activation. The patent also includes nucleic acids encoding these chimeric proteins and methods for reducing inflammation through their administration. He has 1 patent to his name.

Career Highlights

Higgins is currently employed at Cytomed, Inc., where he continues to advance his research and development efforts. His work at Cytomed focuses on innovative solutions to complex medical challenges, particularly those related to immune responses.

Collaborations

Throughout his career, Higgins has collaborated with notable colleagues, including Jone-Long Ko and C. Grace Yeh. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Paul J. Higgins exemplifies the spirit of innovation in biotechnology through his patented work on complement activation. His contributions are vital for advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…